Home/Filings/4/0001209191-22-058934
4//SEC Filing

Lanza Frank J 4

Accession 0001209191-22-058934

CIK 0001708493other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 4:06 PM ET

Size

5.6 KB

Accession

0001209191-22-058934

Insider Transaction Report

Form 4
Period: 2022-11-22
Lanza Frank J
Principal Fin. & Acctng Ofc.
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-11-22+86,43886,438 total
    Exercise: $0.70Exp: 2032-11-21Common Stock (86,438 underlying)
Footnotes (1)
  • [F1]25% of the stock options vest every six months over two years measured from the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Issuer

Harpoon Therapeutics, Inc.

CIK 0001708493

Entity typeother

Related Parties

1
  • filerCIK 0001624055

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 4:06 PM ET
Size
5.6 KB